PTGDR and gastric cancer: Furthermore, AGAP2-AS1 epigenetically suppresses P21 and E-cadherin expression by interacting with EZH2 and LSD1, indicating that AGAP2-AS1 also has oncogenic roles in gastric cancer [74].